Study shows no difference between two common methods for saving lives during cardiac arrest

There is no difference in the effectiveness of the two most commonly used methods for administering medication during out-of-hospital cardiac arrest.

This is shown in a large new clinical study from Aarhus University and Prehospital Services, Region Midtjylland, which compared two ways of accessing the bloodstream: a standard needle in a vein (venous catheter) and a so-called intraosseous needle, which is inserted into the bone marrow.

"When a person suffers cardiac arrest outside the hospital, it is crucial to quickly access the bloodstream to administer life-saving medication. We investigated which method is best," explains Lars Wiuff Andersen, professor and physician at the Department of Clinical Medicine, Aarhus University, Prehospital Services, Region Midtjylland, and Aarhus University Hospital.

Venous catheter or intraosseous needle?

Until now, healthcare professionals have preferred using a venous catheter, but it can be difficult to place as veins may collapse during cardiac arrest.

The intraosseous needle, inserted either into the shinbone or upper arm, can be faster and easier to use in an emergency.

Therefore, it’s interesting to investigate the effectiveness of both methods, explains Lars Wiuff Andersen.

The study, based on data from nearly 1,500 cardiac arrest patients across Denmark, showed that about 30 percent of patients in both groups had their blood circulation restored.

"The two methods proved to be equally effective in restoring blood circulation and saving lives. There was no difference in the patients' survival or quality of life," explains Mikael Fink Vallentin, associate professor at the Department of Clinical Medicine and Prehospital Services, Region Midtjylland, and co-lead author of the study.

May change guidelines

According to the researchers behind the study, the results may impact future guidelines, which previously recommended venous catheters as the first choice.

However, Lars Wiuff Andersen notes that it is too early to say exactly how the guidelines will change.

"Our data must be considered alongside a large clinical trial from the UK, which is being published simultaneously with our study. Combined, these two trials will likely influence guidelines for cardiac arrest treatment, but a thorough review of the results will be needed," he says.

More unanswered questions

There are still several unanswered questions, especially regarding whether specific groups of cardiac arrest patients benefit more from one method than the other.

The researchers are continuing to analyze and compare their own data with data from the UK trial.

The Danish research team has already planned a new, large clinical trial to investigate which method is best for delivering electric shocks during cardiac arrest.

"We hope to gain even more answers on how to best save lives in cardiac arrest in the future," says Lars Wiuff Andersen.

Behind the research results

Study type: Randomized clinical trial

Collaborators: Region Nordjylland, Region Syddanmark, Region Hovedstaden, Region Sjælland

External funding: Novo Nordisk Foundation, Snedkermester Sophus Jacobsen and his wife Astrid Jacobsen's Foundation via the Danish Heart Foundation, Independent Research Fund Denmark, TrygFonden, Aarhus University

Potential conflict of interest: None

Link to scientific article: https://www.nejm.org/doi/full/10.1056/NEJMoa2407616

Contact

Professor and physician Lars Wiuff Andersen
Aarhus University, Department of Clinical Medicine
Prehospital Services, Region Midtjylland
Aarhus University Hospital, Anesthesia, Surgery, and Intensive Care
Phone: +45 51781511
Email: lwandersen@clin.au.dk

Associate Professor and physician Mikael Fink Vallentin
Aarhus University, Department of Clinical Medicine
Prehospital Services, Region Midtjylland
Phone: +45 29918080
Email: mikael.fink.vallentin@clin.au.dk